Nephrology Division, Department of Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, MA.
Dialysis Clinic, Inc., Nashville, TN.
Am J Kidney Dis. 2021 May;77(5):748-756.e1. doi: 10.1053/j.ajkd.2021.01.003. Epub 2021 Jan 17.
RATIONALE & OBJECTIVE: During the coronavirus disease 2019 (COVID-19) pandemic, patients receiving maintenance dialysis are a highly vulnerable population due to their comorbidities and circumstances that limit physical distancing during treatment. This study sought to characterize the risk factors for and outcomes following COVID-19 in this population.
Retrospective cohort study.
SETTING & PARTICIPANTS: Maintenance dialysis patients in clinics of a midsize national dialysis provider that had at least 1 patient who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from February to June 2020.
Demographics, dialysis characteristics, residence in a congregated setting, comorbid conditions, measurements of frailty, and use of selected medications.
COVID-19, defined as having a positive SARS-CoV-2 test result, and all-cause mortality among those with COVID-19.
Logistic regression analyses conducted to identify clinical characteristics associated with COVID-19 and risk factors associated with mortality among patients following COVID-19.
438 of 7948 (5.5%) maintenance dialysis patients developed COVID-19. Male sex, Black race, in-center dialysis (vs home dialysis), treatment at an urban clinic, residence in a congregate setting, and greater comorbidity were associated with contracting COVID-19. Odds of COVID-19 were 17-fold higher for those residing in a congregated setting (odds ratio [OR], 17.10 [95% CI, 13.51-21.54]). Of the 438 maintenance dialysis patients with COVID-19, 109 (24.9%) died. Older age, heart disease, and markers of frailty were associated with mortality.
No distinction was detected between symptomatic and asymptomatic SARS-CoV-2 positivity, with asymptomatic screening limited by testing capacity during this initial COVID-19 surge period.
COVID-19 is common among patients receiving maintenance dialysis, particularly those residing in congregate settings. Among maintenance dialysis patients with COVID-19, mortality is high, exceeding 20%.
在 2019 年冠状病毒病(COVID-19)大流行期间,由于合并症和治疗期间限制身体距离的情况,接受维持性透析的患者是一个高度脆弱的人群。本研究旨在描述该人群 COVID-19 的危险因素和结局。
回顾性队列研究。
一家中等规模全国透析服务提供商的诊所中接受维持性透析的患者,该诊所至少有 1 名患者在 2020 年 2 月至 6 月期间 SARS-CoV-2 严重急性呼吸综合征冠状病毒检测呈阳性。
人口统计学、透析特征、聚居环境居住、合并症、虚弱程度测量以及特定药物的使用。
COVID-19,定义为 SARS-CoV-2 检测结果呈阳性,以及 COVID-19 患者的全因死亡率。
进行逻辑回归分析,以确定与 COVID-19 相关的临床特征和 COVID-19 后与死亡率相关的危险因素。
在 7948 名接受维持性透析的患者中,有 438 名(5.5%)发生了 COVID-19。男性、黑人、中心透析(而非家庭透析)、在城市诊所治疗、聚居环境居住以及更多合并症与 COVID-19 有关。聚居环境居住的患者感染 COVID-19 的可能性高 17 倍(比值比[OR],17.10[95%CI,13.51-21.54])。在 438 名患有 COVID-19 的维持性透析患者中,有 109 人(24.9%)死亡。年龄较大、心脏病和虚弱标志物与死亡率相关。
没有区分有症状和无症状的 SARS-CoV-2 阳性,无症状筛查受到 COVID-19 最初激增期间检测能力的限制。
COVID-19 在接受维持性透析的患者中很常见,特别是那些居住在聚居环境中的患者。在患有 COVID-19 的维持性透析患者中,死亡率很高,超过 20%。